Autolus Therapeutics Announces Changes to its Board of Direc

LONDON, April 01, 2024 -- Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces the appointment of Mike...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , London , City Of , Mike Bonney , Ravi Rao , Olivia Manser , Oxford Biomedica , Johnh Johnson , Roche Genentech , Susana Noonan , Julia Wilson , Cambridge University , Glaxosmithkline , Harvard Medical School , Exchange Commission , Gulf Of Maine Research Institute , Drug Administration , Imperial College London , Zeneca Pharmaceuticals , National Business Director , Alnylam Pharmaceuticals , Bristol Myers Squibb , Nasdaq , Syros Pharmaceuticals , Head Of Research , Imperial College , Member Of The Royal College Physicians , Sv Health Investors , Cubist Pharmaceuticals , Sa Noonan Communications , Bates College , Biologics License Application , B Cell Acute Lymphoblastic Leukemia , Christian Itin , Chief Executive Officer , Vice President , National Business , Dunad Therapeutics , Maine Research , Kaleido Biosciences , Magenta Therapeutics , Sarepta Therapeutics , Chief Medical Officer , Swedish Orphan Biovitrum , Board Member , Venture Partner , Royal College , Honorary Member , Harvard Medical , Autolus Therapeutics , Private Securities Litigation Reform Act , Autolu Annual Report , Markets ,